Added to YB: 2025-02-03
Pitch date: 2025-01-31
DSFIR.AS [bullish]
DSM-Firmenich AG
-28.24%
current return
Author Info
Lux Opes Research covers European companies. Lots of them. Sign up for the newsletter.
Company Info
DSM-Firmenich AG provides nutrition, health, and beauty solutions in Switzerland, the Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia.
Market Cap
EUR 18.0B
Pitch Price
EUR 95.02
Price Target
N/A
Dividend
3.54%
EV/EBITDA
9.17
P/E
26.03
EV/Sales
1.59
Sector
Chemicals
Category
growth
Cognac, Cars and Animal Food - DSM-Firmenich AG
DSFIR.AS: Q4 2024 outlook strong. ANH segment improving on vitamin prices & restructuring, could generate €125m quarterly adj EBITDA. €80m Q4 vitamin tailwind. Perfumery & Beauty driving value. TTH recovering post-destocking. HNC boosted by vitamins. 2025 pivotal if strategy succeeds.
Read full article (1 min)